Podcast


Presenter: Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk

In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately, the evidence shows these medications don’t seem to have a clinically important effect and do have some harms. Have a listen as we give you…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode #615: Vape Expectations: Are electronic cigarettes the real deal for smoking cessation?

In episode 615, Mike and James revisit the evidence around using electronic cigarettes for smoking cessation. We look at smoking cessation rates between the use of e-cigarettes, nicotine-free e-cigarettes, nicotine…
Listen 0.5 credits available

BS Medicine Episode #614: Nipple Confusion or Nonsense? Pacifiers and Breastfeeding Duration

In episode 614, Mike and James discuss with Caitlin Finley the evidence around a very common primary care question. Does restricting early use of pacifiers result in higher rates of…
Listen 0.5 credits available

BS Medicine Episode #613: Doxycycline for post-exposure prophylaxis of sexually transmitted infections

In episode 613, Mike and James discuss with Jessica Kirkwood the evidence for post-exposure prophylaxis of sexually transmitted infections. We go over the 4 RCTs that have looked at the…
Listen 0.5 credits available

Presenter(s):

Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Dr. James McCormack
  • Dr. Mike Allan
  • Dr. Tina Korownyk

Spearkers do not have any conflicts of interest to declare.